The forecast for Canada's import of insulin not in dosage forms indicates a declining trend. From 2024 to 2028, the forecast respectively shows values of 155.45, 146.19, 137.12, 128.22, and 119.51 thousand US dollars. Comparing this trend to the actual imports last recorded in 2023, there is a notable decrease in imports, with the forecast suggesting an average reduction of 6.6% per year over the five-year period from 2024 to 2028.
Future trends to watch include:
- The demand shifts due to advancements in insulin production methods.
- Potential policy changes and trade agreements impacting the import of pharmaceuticals.
- Technological innovations in diabetes care that may influence the import of non-dosage form insulin.
